BPMC

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Blueprint Medicines (BPMC) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

BPMC is expected to report earnings to fall 23.34% to -68 cents per share on February 13

Blueprint Medicines BPMC Stock Earnings Reports

Q4'24

Est.

$-0.68

Q3'24

Beat

by $0.07

Q2'24

Beat

by $0.49

Q1'24

Beat

by $3.07

Q4'23

Beat

by $0.22

The last earnings report on October 30 showed earnings per share of -88 cents, beating the estimate of -95 cents. With 471.84K shares outstanding, the current market capitalization sits at 6.08B.

View a ticker or compare two or three

Compare

BPMC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For BPMC
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for BPMC (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of cancer therapies that harness the growing understanding of the molecular blueprint of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

45 Sidney Street

Phone

+1 617 374-7580

Employees

655

Web

https://www.blueprintmedicines.com